The market is estimated to grow at a CAGR of 6.1% from 2021–2028. The escalating prevalence of joint and orthopedic diseases has also been triggering the demand for joint pain therapy and muscle ailment relief procedures. As per the World Health Organization (WHO) factsheet updated in 2018, musculoskeletal conditions are the second-largest contributor to disabilities worldwide. Moreover, the prevalence and impact of these disorders are expected to rise with the increase in the aging population and rise in many risk factors associated with noncommunicable diseases (NCDs). Further, osteoarthritis (OA), caused by the breakdown of joint cartilage between bones, is one of the most common joint disorders reported in the US. It is also known as degenerative joint disease or “wear and tear” arthritis. As per the Centers for Disease Control and Prevention (CDC), more than 32.5 million adults in the US suffer from OA. According to the National Health Service (NHS) data December 2018, more than 10 million people in the UK have arthritis or similar conditions affecting joints. Gait rehabilitation systems are the primary therapy devices used by people from all age groups, generally without seeking a physician's prescription. Thus, the elevating number of people suffering from sports injuries and orthopedic diseases is contributing to the North America gait rehabilitation system market growth.
Due to the spread of the coronavirus, many cities are being closed, resulting in treatments and cancellations from doctors/surgeons. The patients suffering from critical surgeries such as neurosurgery, spine surgery, and ENT surgery need to be physically conscious and implement procedures in the clinics. Since the coronavirus outbreak reached a pandemic status, the entire North America supply chain has been affected, which has disrupted logistics and production capacities. As a result, COVID-19 has had a significant negative impact on the gait rehabilitation systems market. The COVID-19 pandemic can deprive patients with neurological diseases of their usual care. During the pandemic, there was a tendency towards home exercise programs due to the limited duration of therapy and access to physical therapy. Self-rehabilitation at home is an increasingly common part of rehabilitation programs, especially for various long-term illnesses such as MS.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the gait rehabilitation system market. The North America gait rehabilitation system market is expected to grow at a good CAGR during the forecast period.
Strategic insights for the North America Gait Rehabilitation System provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 127.1 Million |
Market Size by 2028 | US$ 192.4 Million |
Global CAGR (2021 - 2028) | 6.1% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The geographic scope of the North America Gait Rehabilitation System refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The North America Gait Rehabilitation System Market is valued at US$ 127.1 Million in 2021, it is projected to reach US$ 192.4 Million by 2028.
As per our report North America Gait Rehabilitation System Market, the market size is valued at US$ 127.1 Million in 2021, projecting it to reach US$ 192.4 Million by 2028. This translates to a CAGR of approximately 6.1% during the forecast period.
The North America Gait Rehabilitation System Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Gait Rehabilitation System Market report:
The North America Gait Rehabilitation System Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Gait Rehabilitation System Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Gait Rehabilitation System Market value chain can benefit from the information contained in a comprehensive market report.